Ultravalue Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Ultravalue Pharmaceuticals
Ultravalue Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2022 (Two years and eight months 14 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Puralma Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Singh, Rakesh Kumar, Purshottam Bajpai, and Two other members serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51900UP2022PTC165514
- Company No.
165514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ultravalue Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Singh  | Director | 10-Jun-2022 | Current |
| Rakesh Kumar | Director | 10-Jun-2022 | Current |
| Purshottam Bajpai | Director | 10-Jun-2022 | Current |
| Lalan Singh | Director | 10-Jun-2022 | Current |
| Amit Anit | Director | 10-Jun-2022 | Current |
Financial Performance of Ultravalue Pharmaceuticals.
Ultravalue Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ultravalue Pharmaceuticals?
Unlock access to Ultravalue Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Value Formulations Private LimitedPurshottam Bajpai is a mutual person
- Valuemoney Nidhi Limited
Purshottam Bajpai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ultravalue Pharmaceuticals?
Ultravalue Pharmaceuticals has a workforce of 75 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultravalue Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultravalue Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.